Cord Blood Banking
Cord Blood Banking - Related Videos
08:12
Brain Banking: Making the Most of your Research Specimens
0 Views •
Cited by 21 •
2009
Brain banking and systematic sampling of biological material provides the basis for unbiased stereology and maximizes the potential data obtained from each specimen.
14:06
Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
0 Views •
Cited by 2 •
2013
Here we describe a protocol for isolating subsets of precursor B-cells from umbilical cord blood. A sufficient quantity and quality of nucleic acids may be extracted from the cells and used in subsequent assays utilizing DNA or RNA.
07:26
Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood
0 Views •
Cited by 16 •
2017
The goal of this protocol is to isolate endothelial progenitor cells from umbilical cord blood. Some of the applications include using these cells as a biomarker for identifying patients with cardiovascular risk, treating ischemic diseases, and creating tissue-engineered vascular and heart valve constructs.
09:19
Contrast Enhanced Ultrasound Imaging for Assessment of Spinal Cord Blood Flow in Experimental Spinal Cord Injury
0 Views •
Cited by 16 •
2015
Contrast Enhanced Ultrasound imaging is a reliable in-vivo tool for quantifying spinal cord blood flow in an experimental rat spinal cord injury model. This paper contains a comprehensive protocol for application of this technique in association with a contusion model of thoracic spinal cord injury.
01:23
The Central Bank
0 Views •
2025
The central bank is responsible for conducting monetary policy in a country. Although central banks share similar responsibilities across countries, their organizational structures can vary.In the United States, the Federal Reserve System, known as the Federal Reserve or simply the Fed, is the central bank. The Federal Reserve is composed of three core components.The first component is the Federal Reserve Board of Governors, a government body located in Washington, D.C. It consists of seven...
FAQs
The key biological value lies in the blood-forming stem and progenitor cells within the collected sample. These cells can support hematopoietic stem cell transplantation, a treatment approach used for selected conditions. Their usefulness depends on preserving viable cells during processing and cryogenic storage, rather than merely retaining the original volume of cord blood.
Cell dose and sample quality directly influence whether a stored unit can be considered useful for transplantation. A larger cellular yield does not by itself guarantee suitability, because testing and processing also determine the condition and concentration of the preserved material. Evaluating these factors helps distinguish a viable candidate from a unit with limited potential.
Compatibility matters because a stored unit is not evaluated in isolation; its suitability depends partly on the relationship between the donor source and intended recipient. This assessment helps determine whether a unit can support a particular transplantation decision. Consequently, preserved units are not interchangeable, and compatibility remains a distinct consideration alongside cell dose and sample quality.
Controlled cryogenic storage matters because the cellular fraction must remain viable for possible later use. Processing can separate or concentrate the cells before freezing, while controlled conditions help preserve the state of that material during storage. This makes the stored unit more suitable for later evaluation and potential transplantation or research than an untreated sample.
Testing and cellular processing are performed before freezing to characterize and prepare the material for storage. The sample may be examined, while its cellular fraction is separated or concentrated under controlled handling. These steps help document sample quality and cell dose, two factors later considered when judging whether a unit has potential for transplantation or research.
Stored units may support hematopoietic stem cell transplantation for selected blood cancers, inherited blood disorders, and immune deficiencies. The relevant outcome is not simply that a unit exists, but that its cells remain sufficiently viable and appropriate for the intended recipient. Cord blood banking therefore connects preservation with carefully selected clinical uses rather than universal treatment.
Beyond transplantation, stored cord blood can serve as biological material for research on cell therapies and genetic disease. In this setting, the unit's value lies in providing preserved blood-forming stem and progenitor cells for investigation, rather than immediately treating a patient. This broadens cord blood banking's role from clinical cell storage to a resource for studying therapeutic and disease-related questions.